as on November 5, 2025 at 2:29 am IST
Day's Low
Day's High
1.15%
Downside
1.30%
Upside
52 Week's Low
52 Week's High
48.36%
Downside
29.32%
Upside
Check Charles River Laboratories International market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.9B
EPS (TTM)
10.1899
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.39%
PE Ratio (TTM)
23.31
Industry PE ratio
19.200384615384614
PEG Ratio
0.1339
EBITDA
955.7M
Revenue (TTM)
4.0B
Profit Margin
-1.66%
Return On Equity TTM
-1.81%
Track how Charles River Laboratories International P/E has moved over time to understand its valuation trends.
Charles River Laboratories International in the last 5 years
Lowest (12.45x)
June 30, 2025
Industry (19.20x)
November 4, 2025
Today (23.31x)
November 4, 2025
Highest (40.60x)
September 30, 2021
Today’s Price to Earnings Ratio: 23.31x
Compare market cap, revenue, PE, and other key metrics of Charles River Laboratories International with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.9B | -28.25% | 23.31 | -1.66% | |
| BUY | $50.4B | 54.03% | 52.37 | 24.41% | |
| BUY | $214.3B | 10.55% | 32.78 | 15.02% | |
| BUY | $41.5B | 33.37% | 34.28 | 17.97% | |
| BUY | $36.4B | 25.15% | 29.42 | 8.07% |
The Charles River Laboratories International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Charles River Laboratories International investment value today
Current value as on today
₹1,03,121
Returns
₹3,121
(+3.12%)
Returns from Charles River Laboratories International Stock
Dollar Returns*
₹5,648 (+5.65%)
Based on 21 analysts
61.90%
Buy
38.10%
Hold
0.00%
Sell
Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Charles River Laboratories International. Average target price of $186.87
Get share price movements and forecasts by analysts on Charles River Laboratories International.
What analysts predicted
4.82%UPSIDE
Target Price
$186.87
Current Price
$177.87
Analyzed by
21 Analysts
Target
$186.87
Charles River Laboratories International target price $186.87, a slight upside of 4.82% compared to current price of $177.87. According to 21 analysts rating.
Search interest for Charles River Laboratories International Stock has increased by 136% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:136% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 22 October
Wed, 06:50 PM
-Charles River and The Francis Crick Institute collaborate on Antibody-Drug Conjugate development to accelerate targeted therapies.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 984.16M → 1.03B (in $), with an average increase of 4.7% per quarter
Price Rise
![]()
In the last 6 months, CRL stock has moved up by 51.0%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -215.69M → 52.32M (in $), with an average increase of 499.1% per quarter
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 94.4% return, outperforming this stock by 113.2%
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 74.4% return, outperforming this stock by 76.4%
| Organisation | Charles River Laboratories International |
| Headquarters | 251 Ballardvale Street, Wilmington, MA, United States, 01887 |
| Industry | Commercial Services |
| CEO | Mr. James C. Foster J.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mark Mintz | Corporate EVP, Chief Information Officer & Global Shared Services |
Mr. Matthew L. Daniel J.D. | Corporate Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
Ms. Amy E. Cianciaruso | Corporate Senior Vice President, Chief Communications Officer & Government Relations |
Ms. Birgit Girshick | Corporate Executive VP & COO |
Mr. Joseph W. LaPlume J.D. | Corporate Executive Vice President of Corporate Development & Strategy |
Mr. Michael Gunnar Knell | Interim CFO, Corporate Senior VP & Chief Accounting Officer |
Prof. Julie Frearson Ph.D. | Corporate Senior VP & Chief Scientific Officer |
Mr. Todd Spencer | Corporate Vice President of Investor Relations |
Mr. James C. Foster J.D. | Chairman, President & CEO |
Ms. Victoria L. Creamer | Corporate Executive VP & Chief People Officer |
Charles River Laboratories International share price today is $177.87 as on at the close of the market. Charles River Laboratories International share today touched a day high of $180.19 and a low of $175.83.
Charles River Laboratories International share touched a 52 week high of $230.02 on and a 52 week low of $91.86 on . Charles River Laboratories International stock price today i.e. is closed at $177.87,which is 22.67% down from its 52 week high and 93.63% up from its 52 week low.
Charles River Laboratories International market capitalisation is $0.01T as on .
Indian investors can start investing in Charles River Laboratories International (CRL) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Charles River Laboratories International stock (as per the Rupee-Dollar exchange rate as on ).
Based on Charles River Laboratories International share’s latest price of $177.87 as on November 5, 2025 at 2:29 am IST, you will get 0.0562 shares of Charles River Laboratories International. Learn more about
fractional shares .
Charles River Laboratories International stock has given -28.25% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?